Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 406992
Gene Symbol: MIR210
MIR210
0.020 Biomarker disease BEFREE MiR-210 can be involved in the apoptosis process of vascular endothelial cells in ASO through the JAK-STAT signaling pathway. 31389592 2019
Entrez Id: 406991
Gene Symbol: MIR21
MIR21
0.020 AlteredExpression disease BEFREE miR-21 was upregulated in arteries of ASO, the pathogenesis of which involved the activation of p-AKT and p-ERK1/2. 31749878 2019
Entrez Id: 406991
Gene Symbol: MIR21
MIR21
0.020 Biomarker disease BEFREE The hypoxia inducible factor-1 α/miR-21/tropomyosin 1 pathway may play a critical role in the pathogenesis of ASO. 21817107 2011
Entrez Id: 406992
Gene Symbol: MIR210
MIR210
0.020 Biomarker disease BEFREE The serum levels of miR-130a, miR-27b and miR-210 may serve as potential biomarkers for early stage ASO. 20888330 2011
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.020 Biomarker disease BEFREE This is the first report on the usefulness of Tc-99m-MIBI scintigraphy to evaluate the effectiveness of HGF gene therapy for peripheral arteriosclerosis obliterans. 19225945 2009
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.020 AlteredExpression disease LHGDN Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans. 18175063 2008
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.020 AlteredExpression disease LHGDN Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. 15877296 2005
Entrez Id: 3082
Gene Symbol: HGF
HGF
0.020 Biomarker disease BEFREE Consistent with in vitro findings that hypoxia downregulated vascular HGF production, vascular HGF concentration in the diseased segments of vessels from patients with arteriosclerosis obliterans was significantly decreased as compared with disease-free segments from the same patients (P<0.05), accompanied by a marked reduction in HGF mRNA. 10373220 1999
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.010 Biomarker disease BEFREE MiR-126 promotes endothelial cell apoptosis by targeting PI3K/Akt in rats with lower limb arteriosclerosis obliterans. 31389593 2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.010 Biomarker disease BEFREE MiR-126 promotes endothelial cell apoptosis by targeting PI3K/Akt in rats with lower limb arteriosclerosis obliterans. 31389593 2019
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.010 Biomarker disease BEFREE MiR-126 promotes endothelial cell apoptosis by targeting PI3K/Akt in rats with lower limb arteriosclerosis obliterans. 31389593 2019
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.010 AlteredExpression disease BEFREE miR-21 was upregulated in arteries of ASO, the pathogenesis of which involved the activation of p-AKT and p-ERK1/2. 31749878 2019
Entrez Id: 6646
Gene Symbol: SOAT1
SOAT1
0.010 Biomarker disease BEFREE MiR-210 inhibits apoptosis of vascular endothelial cells via JAK-STAT in arteriosclerosis obliterans. 31389592 2019
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.010 Biomarker disease BEFREE MiR-126 promotes endothelial cell apoptosis by targeting PI3K/Akt in rats with lower limb arteriosclerosis obliterans. 31389593 2019
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.010 Biomarker disease BEFREE Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans. 31086587 2019
Entrez Id: 407021
Gene Symbol: MIR29A
MIR29A
0.010 AlteredExpression disease BEFREE This study showed that miR-29a is downregulated in the arterial wall of ASO patients, as well as in the PDGF-BB-stimulated HASMCs. 31614351 2019
Entrez Id: 406913
Gene Symbol: MIR126
MIR126
0.010 Biomarker disease BEFREE In rats with lower limb arteriosclerosis obliterans (ASO), miR-126 represses the PI3K/Akt signaling pathway to accelerate endothelial cell apoptosis. 31389593 2019
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.010 Biomarker disease BEFREE The clinical usefulness of peripheral blood (PB) mononuclear cell (MNC) transplantation in patients with peripheral arterial disease (PAD), especially in those with mild-to-moderate severity, has not been fully clarified.Methods and Results:A randomized clinical trial was conducted to evaluate the efficacy and safety of granulocyte colony-stimulating factor (G-CSF)-mobilized PBMNC transplantation in patients with PAD (Fontaine stage II-IV and Rutherford category 1-5) caused by arteriosclerosis obliterans or Buerger's disease. 29877199 2018
Entrez Id: 9927
Gene Symbol: MFN2
MFN2
0.010 Biomarker disease BEFREE The results of the present study provide novel insight into the underlying mechanisms and roles of miR-31/MFN2 in the pathology of ASO, which may offer a potential therapeutic target for the treatment of ASO. 29403548 2018
Entrez Id: 93145
Gene Symbol: OLFM2
OLFM2
0.010 Biomarker disease BEFREE The aim of the present study was to investigate circulating OLFM2 levels in lower extremity arteriosclerosis obliterans (LEASO) patients and the association of OLFM2 with postoperative restenosis in patients. 29553861 2018
Entrez Id: 407035
Gene Symbol: MIR31
MIR31
0.010 AlteredExpression disease BEFREE In the present study, miR-31 expression was detected by reverse transcription-quantitative polymerase chain reaction and <i>in situ</i> hybridization, and was significantly upregulated in human ASO arterial walls compared with normal arterial walls (P<0.001). 29403548 2018
Entrez Id: 6722
Gene Symbol: SRF
SRF
0.010 AlteredExpression disease BEFREE These findings demonstrate a specific role of the miR-125b/SRF pathway in regulating VSMC function and suggest that modulating miR-125b levels might be a novel approach for treating ASO. 29689557 2018
Entrez Id: 4615
Gene Symbol: MYD88
MYD88
0.010 Biomarker disease BEFREE Therefore, we discuss the possibility that the pathogenesis of this disease is due to a type of gene polymorphism, which leads to an immunological inflammatory vasculitis associated with tobacco abuse, highly linked to T cells, human vascular endothelial cells (HVECs), and the TLR-MyD88-NFκB pathway, distinct from arteriosclerosis obliterans and other vasculitides. 28864202 2017
Entrez Id: 407004
Gene Symbol: MIR22
MIR22
0.010 AlteredExpression disease BEFREE Furthermore, miR-22-3p expression was negatively correlated with HMGB1 expression in ASO tissue specimens. 28848136 2017
Entrez Id: 22900
Gene Symbol: CARD8
CARD8
0.010 GeneticVariation disease BEFREE The primary objective of this study was to investigate the association between polymorphism of CARD8 rs2043211 and susceptibility to arteriosclerosis obliterans (ASO) in Chinese Han male population. 28135700 2017